Chemoinformaics analysis of 1-ethynyl-Cyclohexanol
| Molecular Weight | 124.183 | nRot | 0 |
| Heavy Atom Molecular Weight | 112.087 | nRig | 7 |
| Exact Molecular Weight | 124.089 | nRing | 1 |
| Solubility: LogS | -1.427 | nHRing | 0 |
| Solubility: LogP | 1.433 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 22.1635 |
| nHD | 1 | BPOL | 12.0385 |
| QED | 0.483 |
| Synth | 2.89 |
| Natural Product Likeliness | 0.517 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.334 |
| MDCK | 0.0000251 |
| BBB | 0.998 |
| PPB | 0.711629 |
| VDSS | 1.171 |
| FU | 0.0777365 |
| CYP1A2-inh | 0.473 |
| CYP1A2-sub | 0.888 |
| CYP2c19-inh | 0.578 |
| CYP2c19-sub | 0.848 |
| CYP2c9-inh | 0.134 |
| CYP2c9-sub | 0.885 |
| CYP2d6-inh | 0.175 |
| CYP2d6-sub | 0.429 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.14 |
| CL | 6.79 |
| T12 | 0.51 |
| hERG | 0.015 |
| Ames | 0.064 |
| ROA | 0.456 |
| SkinSen | 0.124 |
| Carcinogencity | 0.871 |
| EI | 0.988 |
| Respiratory | 0.947 |
| NR-Aromatase | 0.024 |
| Antiviral | No |
| Prediction | 0.950284 |